Skip navigation

Pharma's Market


Current DateTime: 10:33:59 10 Feb 2012
LinksList Documentid: 23279705
Expiration DateTime: 2/10/2012 10:36:05 AM

SPECIAL REPORT


Current DateTime: 10:34:00 10 Feb 2012
LinksList Documentid: 32984624

MOST SHARED


Current DateTime: 10:33:59 10 Feb 2012
LinksList Documentid: 31330905
Expiration DateTime: 2/10/2012 10:36:45 AM

Current DateTime: 10:34:00 10 Feb 2012
LinksList Documentid: 23452000
Expiration DateTime: 2/10/2012 10:36:40 AM

Current DateTime: 10:34:00 10 Feb 2012
LinksList Documentid: 23452764
Expiration DateTime: 2/10/2012 10:36:24 AM

PHARMA'S MARKET VIDEO

» More

Current DateTime: 10:34:00 10 Feb 2012
LinksList Documentid: 31171988
Expiration DateTime: 2/10/2012 10:36:08 AM

RSS FEED

» Help

Current DateTime: 10:34:01 10 Feb 2012
LinksList Documentid: 31171995

Does Glaxo's Ad Campaign Suck Or What?

Published: Tuesday, 22 Dec 2009 | 11:27 AM ET
Text Size
By: Mike Huckman
CNBC Correspondent

It's New Year's resolution time, so it's no surprise to see a sudden increase in commercials and ads for stop-smoking products. Pfizer's [PFE  Loading...      ()   ] been heavily pushing its challenged Chantix and the other day I saw a commercial for GlaxoSmithKline's [GSK  Loading...      ()   ] Nicorette that nearly made my jaw drop.

Source: nicorette.com

I'm not a prude, but I was kind of shocked at what I saw and heard from this monolithic, conservative pharmaceutical company.

The new tagline is, "Nicorette makes quitting suck less." Wow. "Suck" makes its way into a primetime commercial for a big pharma product.

Who'da thunk it?

I mean, the CEO won't even do a TV interview for crying out loud because he's supposedly uncomfortable in front of the camera, but he'll greenlight a prominent ad campaign with the word "suck" in it? Gimme a break.

Glaxo says it sold $128 million dollars worth of "nicotene replacement therapy" products in the third quarter of this year. That's a relatively small number, but not necessarily immaterial. It's also down from $157 million in the third quarter last year when the company broke them out as "smoking cessation products." I don't know what the semantic change was all about. But it would totally suck for GSK if Nicorette sales went down again, especially at a time of year when nicotene replacement therapy and smoking cessation product sales tend to go up.

Questions?  Comments?  and follow me on Twitter at mhuckman

© 2012 CNBC, Inc. All Rights Reserved


Current DateTime: 09:37:12 10 Feb 2012
LinksList Documentid: 29778428

Current DateTime: 09:37:11 10 Feb 2012
LinksList Documentid: 29779196

Current DateTime: 10:10:42 10 Feb 2012
LinksList Documentid: 29779197

Current DateTime: 09:37:12 10 Feb 2012
LinksList Documentid: 29779199
CNBCCNBC
About CNBC  |  Site Map  |  Video Reprints   |  Advertise  |  Help  |  Contact
Privacy Policy  |     |  Terms of Service  |  Independent Programming Report
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2012 CNBC LLC.  All Rights Reserved.
A Division of NBCUniversal
Thomson ReutersThomson Reuters